UNIVERSAL HEALTH SERVICES INC (UHS) Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
Sector: Services-General Medical & Surgical Hospitals, NEC
Industry: Medical - Care Facilities
Universal Health Services, Inc. NYSE:UHS Healthcare · Medical - Care Facilities
Mkt Cap $11.01B
Div Yield 0.43%
AH Close $186.89 +0.00% vs close
AH Close $186.89 +0.00% vs close
Mkt Cap $11.01B
Div Yield 0.43%
All Press Release SEC Filings News
Press Release
Universal Health Services, Inc. Announces Date and Time Change for Third Quarter 2026 Earnings Release and Conference Call
Universal Health Services will now report Q3 2026 results after market close on Tuesday, October 27, 2026.
The investor and analyst conference call is scheduled for 8:00 a.m. ET on Wednesday, October 28, 2026, with a live webcast available at ir.uhs.com.
The company said the change was made to avoid conflicts with other healthcare conference calls; no financial figures were included in the notice.
• 16d ago AI analysis › Press Release
Universal Health Services, Inc. Announces Date for Third Quarter 2026 Earnings Release and Conference Call
Universal Health Services will report third quarter 2026 results after the market close on Monday, October 26, 2026.
An investor and analyst conference call is scheduled for Tuesday, October 27, 2026, at 9:30 a.m. Eastern Time, with a live webcast available on the company's investor relations site.
• 20d ago AI analysis › Press Release
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES
Universal Health Services announced its management will present at three upcoming healthcare conferences in September.
Presentations are scheduled for the Wells Fargo Healthcare Conference on Sept. 8, the Morgan Stanley Global Healthcare Conference on Sept. 14, and the Baird Global Healthcare Conference on Sept. 15.
Live audio webcasts and replays will be accessible via the Investor Relations section of the company's website.
• 2mo ago AI analysis › SEC Filing ⚠ 4
UHS: 8-K · debt financing
Universal Health Services completed a $1.1 billion public offering of senior secured notes on August 20, 2026, consisting of $600 million of 5.500% notes due September 1, 2031 and $500 million of 6.000% notes due September 1, 2036.
The notes are guaranteed and secured on a first-priority basis by UHS subsidiaries and rank equally with the company's senior secured credit facility and five existing secured note series. Both Moody's and S&P assigned investment grade ratings at issuance, and holders receive a 101% change-of-control put only if the ratings fall below investment grade.
The offering was led by J.P. Morgan, BofA Securities, Truist, U.S. Bancorp Investments and Wells Fargo Securities, with a portion of proceeds used to repay outstanding revolving credit facility borrowings. J.P. Morgan Securities also served as UHS's financial advisor on its recent acquisition of Talkspace.
SEC 8-K • 2mo ago AI analysis › Press Release ● Critical
Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.
Universal Health Services (UHS) has completed its acquisition of Talkspace, combining one of the nation's largest healthcare providers with a leading virtual behavioral health platform.
The transaction creates an end-to-end ecosystem connecting virtual care with inpatient and outpatient facilities to support patients across all levels of need.
Talkspace's network of approximately 6,000 licensed providers and its new AI-powered guide, Tee, will now integrate with UHS's network, which serves more than 200 million people.
• 2mo ago AI analysis › SEC Filing ⚠ 4
UHS: 8-K · debt financing
Universal Health Services entered into an underwriting agreement on August 11, 2026 to issue and sell $1.1 billion of senior secured notes in two tranches: $600 million of 5.500% notes due September 1, 2031 and $500 million of 6.000% notes due September 1, 2036. The offering is expected to close on August 20, 2026.
UHS intends to use the proceeds to repay its $700 million of 1.650% senior secured notes at their September 2026 maturity, pay down amounts outstanding under its revolving credit facility, and fund general corporate purposes.
The notes priced at 99.937% and 99.359% of par, for yields to maturity of 5.514% and 6.086% and spreads of 112.5 and 140 basis points over Treasuries, with expected ratings of Baa3/BBB-/BBB-. The refinancing replaces 1.65% debt with coupons roughly 3.9 to 4.4 percentage points higher, locking in a materially higher interest cost on this portion of the capital structure.
The notes are secured by first-priority liens on collateral shared with UHS's credit facilities and existing secured notes, and guaranteed by subsidiary guarantors. The filing also discloses that J.P. Morgan Securities is serving as UHS's financial advisor on its proposed acquisition of Talkspace, Inc.
SEC 8-K • 2mo ago AI analysis › SEC Filing ⚠ 10
UHS: 10-Q · periodic report
Universal Health Services reported Q2 2026 net revenues of $4.64 billion, up 8.3% year over year, with net income attributable to UHS of $358.4 million and diluted EPS of $5.98 versus $5.43 a year ago. First-half revenue reached $9.13 billion, up 8.9%, with diluted EPS of $11.63 versus $10.23 in the prior-year period.
Per-share growth was amplified by buybacks: UHS repurchased $484.6 million of stock in the first half of 2026, cutting the Q2 diluted share count to 59.9 million from 65.0 million. The company expects to close its approximately $835 million acquisition of virtual behavioral health provider Talkspace at $5.25 per share in Q3 2026, funded with borrowings under a credit agreement expanded by $900 million in April 2026 plus a new $700 million delayed-draw loan arranged in July 2026.
Offsets to the growth are mounting: results include a $28 million pre-tax increase to professional and general liability reserves, Laurel Ridge Treatment Center was terminated from Medicare and Medicaid effective April 30, 2026 (the facility earned about $23 million pre-tax in 2025), and both campuses of Provo Canyon School had licenses revoked in July 2026. The Cumberland Hospital litigation also remains open with roughly 43 additional plaintiffs pending, and the President of Behavioral Health has resigned with CEO Marc Miller covering the segment on an interim basis.
SEC 10-Q • 2mo ago AI analysis › SEC Filing ⚠ 5
UHS: 8-K · earnings release
Universal Health Services reported strong Q2 2026 results with net revenue increasing 8.3% to $4.638 billion and net income rising to $358.4 million or $5.98 per diluted share, compared to $353.2 million or $5.43 per diluted share in Q2 2025. For the first six months of 2026, revenue grew 8.9% to $9.133 billion, with net income reaching $707.1 million or $11.63 per diluted share, up from $669.9 million or $10.23 per diluted share in the same period last year.
Despite solid quarterly performance, UHS revised its full-year 2026 forecast downward, with Adjusted EPS guidance of $22.28-$23.65 per share, representing a 2.6% decrease at the midpoint compared to its original forecast. The company cited changes in Medicaid supplemental payment programs and the inclusion of a $100 million favorable pre-tax impact from Florida Medicaid directed payments that are not expected to recur beyond September 2025.
The company repurchased 1.89 million shares during the second quarter at a cost of $320.3 million, with $977.6 million remaining in its repurchase authorization. UHS also amended its credit agreement to add a new $700 million delayed draw term loan facility, which could be used to repay $700 million of 1.650% Senior Secured Notes due September 1, 2026.
SEC 8-K • 2mo ago AI analysis › Press Release ● Major ⚠ 3
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026, AND REVISES 2026 FULL YEAR OPERATING RESULTS FORECAST
Universal Health Services reported Q2 2026 revenue of $4.64 billion, up 8.3% year-over-year, with diluted EPS rising to $5.98 from $5.43 in the prior year.
The company revised its full-year 2026 forecast, slightly raising the revenue midpoint but lowering Adjusted EBITDA and Adjusted EPS outlooks by 1.9% and 2.6%, respectively, due to reserve increases and reimbursement changes.
Operational metrics showed solid growth in both acute care and behavioral health segments, while the company repurchased $320 million of stock during the quarter, leaving approximately $978 million remaining in its authorization.
• 2mo ago AI analysis › SEC Filing
UHS: 8-K · debt financing
Universal Health Services, Inc. entered into a Twelfth Amendment to its Credit Agreement, adding a new incremental delayed draw tranche A term loan facility of up to $700 million. This new facility, designated as the July 2026 Delayed Draw Term Loan, allows the company to borrow funds between July 20, 2026, and September 30, 2026.
The loan has a maturity of 364 days from the funding date and carries an applicable margin based on the company's Consolidated Net Leverage Ratio, initially set at 0.125% for ABR loans and 1.125% for Term Benchmark or RFR loans. The obligations under this facility are secured on an equal ratable basis with holders of the company's existing senior secured notes.
Proceeds from the facility are intended for general corporate purposes, which may include the refinancing of existing indebtedness. JPMorgan Chase Bank, N.A. serves as the administrative agent for the credit agreement.
SEC 8-K • 3mo ago AI analysis › Press Release
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
Universal Health Services' Board of Directors declared a cash dividend of $0.20 per share.
The dividend is payable on September 15, 2026 to shareholders of record as of September 1, 2026.
UHS operates acute care hospitals and behavioral health facilities across the US, Puerto Rico, and the UK.
• 3mo ago AI analysis › Press Release
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
Universal Health Services announced it will report its second quarter 2026 financial results after the market closes on Monday, July 27, 2026.
The company will host a conference call for investors and analysts on Tuesday, July 28, 2026, at 9:00 a.m. Eastern Time.
Investors can access the live webcast or register for telephone participation through the investor relations section of the company's website.
• 3mo ago AI analysis › Press Release
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT GOLDMAN SACHS ANNUAL GLOBAL HEALTHCARE CONFERENCE
Universal Health Services will present at the Goldman Sachs Annual Global Healthcare Conference on June 9, 2026, at 8:00am ET.
The presentation will be available via live audio webcast and replay on the company's Investor Relations website.
This is a standard investor relations calendar update with no new operational or financial disclosures.
• 4mo ago AI analysis › Press Release
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
Universal Health Services declared a quarterly cash dividend of $0.20 per share.
The dividend is payable on June 18, 2026, to shareholders of record as of June 8, 2026.
This is a routine maintenance of the existing dividend policy with no announced changes to the rate.
• 4mo ago AI analysis › SEC Filing
UHS: 8-K · proxy statement
Universal Health Services, Inc. (UHS) held its 2026 Annual Meeting of Stockholders on May 20, 2026, conducting the event virtually via live audio webcast.
Stockholders elected Alan B. Miller and Nina Chen-Langenmayr as Class III directors for three-year terms expiring in 2029. The advisory vote on executive compensation passed overwhelmingly, with over 62 million votes in favor versus approximately 228,000 against.
The ratification of PricewaterhouseCoopers, LLP as the independent auditor also passed with strong support. A stockholder proposal to report votes based on shareholder money at risk was defeated, receiving only about 2.9 million votes in favor compared to nearly 59.5 million against.
SEC 8-K • 5mo ago SEC Filing
UHS: 8-K · leadership change
Matthew J. Peterson, Executive Vice President and President of Behavioral Health, has resigned effective June 19, 2026, to pursue an external career opportunity. Mr. Peterson, who has been with the company since 2019, will forfeit all unvested stock options, restricted stock units, and performance-based restricted stock units upon his departure.
Marc D. Miller, Chief Executive Officer and President, will assume interim responsibilities for the Behavioral Health Care Division along with the division's Senior Vice Presidents. The company stated it will immediately commence a search for a permanent replacement to lead the division.
SEC 8-K • 5mo ago AI analysis › Press Release ● Major
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2026
UHS delivered strong Q1 2026 results with net revenue rising 9.6% year-over-year to $4.495 billion and diluted EPS growing 17.7% to $5.65, fueled by pricing gains in both Acute Care and Behavioral Health.
Adjusted EBITDA increased 8.4% to $648.3 million and operating cash flow improved to $401.6 million.
The company amended its credit agreement to increase capacity by $900 million, including a $400 million delayed-draw term loan for the pending Talkspace acquisition, while simultaneously repurchasing $127.3 million of shares.
• 5mo ago AI analysis › 
